| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.45 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |